Keynatinib in Treated Patients With NSCLC and Brain Metastases

Clinical trial NCT04824079 · COMPLETED

Trial details

NCT number: NCT04824079
Sponsor: Medolution Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer With EGFR Mutation Brain Metastases

Start date: 2020-10-21
Primary completion: 2024-12-10
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.